Correlation Between SAB Biotherapeutics and Sage Therapeutic
Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and Sage Therapeutic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and Sage Therapeutic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SAB Biotherapeutics and Sage Therapeutic, you can compare the effects of market volatilities on SAB Biotherapeutics and Sage Therapeutic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of Sage Therapeutic. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and Sage Therapeutic.
Diversification Opportunities for SAB Biotherapeutics and Sage Therapeutic
-0.41 | Correlation Coefficient |
Very good diversification
The 3 months correlation between SAB and Sage is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and Sage Therapeutic in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sage Therapeutic and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with Sage Therapeutic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sage Therapeutic has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and Sage Therapeutic go up and down completely randomly.
Pair Corralation between SAB Biotherapeutics and Sage Therapeutic
Assuming the 90 days horizon SAB Biotherapeutics is expected to generate 3.24 times more return on investment than Sage Therapeutic. However, SAB Biotherapeutics is 3.24 times more volatile than Sage Therapeutic. It trades about 0.03 of its potential returns per unit of risk. Sage Therapeutic is currently generating about -0.12 per unit of risk. If you would invest 2.55 in SAB Biotherapeutics on January 6, 2025 and sell it today you would lose (0.05) from holding SAB Biotherapeutics or give up 1.96% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 72.73% |
| Values | Daily Returns |
SAB Biotherapeutics vs. Sage Therapeutic
Performance |
| Timeline |
| SAB Biotherapeutics |
| Sage Therapeutic |
SAB Biotherapeutics and Sage Therapeutic Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with SAB Biotherapeutics and Sage Therapeutic
The main advantage of trading using opposite SAB Biotherapeutics and Sage Therapeutic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, Sage Therapeutic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sage Therapeutic will offset losses from the drop in Sage Therapeutic's long position.| SAB Biotherapeutics vs. Intracellular Th | SAB Biotherapeutics vs. Amphastar P | SAB Biotherapeutics vs. Assertio Therapeutics | SAB Biotherapeutics vs. ANI Pharmaceuticals |
| Sage Therapeutic vs. Apellis Pharmaceuticals | Sage Therapeutic vs. Terns Pharmaceuticals | Sage Therapeutic vs. Day One Biopharmaceuticals | Sage Therapeutic vs. Blueprint Medicines Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |